Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Transition of Promotional Activities for Allergen Immunotherapy Drug Actair® in Japan
Friday, July 04, 2025Stallergenes Greer Shionogi Co Ltdand CEOLIA Pharma Co Ltd CEOLIA today announced the transition of promotional activities for Actair in Japan Actair is Stallergenes Greers sublingual immunotherapy
FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial
Thursday, July 03, 2025Merck known as MSD outside of the United States and Canada today announced that the US Food and Drug Administration FDA has accepted and granted priority review for a new supplemental Biologics License Application
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
Wednesday, July 02, 2025Alvotecha global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited Advanz Pharma a UK headquartered global pharmaceutical company
ValGenesis and CAI Partner to Advance AI-Enabled Digital Validation in Life Sciences
Wednesday, July 02, 2025ValGenesis Inc the global leader in digital validation lifecycle management today announced a strategic partnership with CAI a professional services firm specializing in accelerating operational readiness in missioncritical environments
Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS
Tuesday, July 01, 2025Klotho Neurosciences Inctoday announced that it is moving forward with manufacturing and process development work in preparation for clinical trials of KLTO its investigational gene therapy for amyotrophic lateral sclerosis ALS
Chai Discovery Unveils Chai-2 Breakthrough, Achieving Fully De Novo Antibody Design With AI
Tuesday, July 01, 2025Chai Discovery which builds frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules today announced a breakthrough in the de novo design of antibodies
Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders
Monday, June 30, 2025Addex Therapeutics a clinicalstage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders today announced it has led a CHF million
Aenova expands cold chain capabilities with new state-of-the-art warehouse at its sterile site in Latina
Monday, June 30, 2025Aenova a leading global contract development and manufacturing organization CDMO is investing in a new cold chain warehouse at its sterile site in Latina Italy The cuttingedge facility marks a significant milestone in Aenovas
Prokaryotics Announces Licensing Agreement with Northern Antibiotics for Novel Gram-negative Antibiotic Potentiator
Friday, June 27, 2025Prokaryotics Inc a privatelyheld biopharmaceutical company engaged in the discovery and development of novel antiinfective drugs announced today that it has entered into a licensing agreement with Northern Antibiotics on June
LIfT BioSciences Expands U.S. Footprint with New Facility at Portal Innovations, Houston Helix Park
Thursday, June 26, 2025LIfT BioSciencesa rapidly emerging biotech and the global leader in neutrophil immunotherapies today announces it has entered into an agreement with Portal Innovations a life sciences venture capital firm
